Last updated: August 4, 2025
Introduction
Russian patent RU2012101491 pertains to a pharmaceutical invention registered within the Russian Federation’s national patent system. Analyzing its scope, claims, and landscape provides clarity on its innovation protection, commercial viability, and competitive positioning. This review synthesizes available patent documents, legal standards, and market context to deliver a comprehensive understanding.
Patent Overview
Patent Number: RU2012101491
Application Filing Date: August 27, 2012
Publication Date: April 24, 2013
Inventor(s): (Details typically available from the patent document)
Applicant: (Applicant information from the patent record)
Patent Status: Granted
This patent falls under the class of pharmacological inventions, specifically related to a pharmaceutical composition, method of treatment, or a specific active ingredient formulation.
Scope and Claims Analysis
The scope of RU2012101491 primarily hinges on the independent claims, which legally define the boundaries of the patent’s protection. The claims detail the novel elements that distinguish the invention from prior art, thereby providing the basis for enforcement and licensing.
Key Elements of the Patent Claims
-
Composition or Formulation Claims:
If the patent discloses a specific combination of active pharmaceutical ingredients (APIs), excipients, or delivery mechanisms, these are detailed in the claims. For instance, the patent might claim a particular ratio or synthesis method for a drug aimed at treating a specific condition.
-
Method of Use Claims:
Claims may encompass novel therapeutic methods, dosing regimens, or administration routes. This broadens protection to not only the composition but also its application.
-
Process Claims:
The patent might also claim a unique manufacturing process or purification method, which provides competitive advantages or enhances the drug’s stability and efficacy.
-
Device or Delivery System Claims:
If the patent includes specialized delivery devices or formulations (e.g., sustained-release systems), these elements are also covered within its scope.
Claim Language and Limitations
The claims appear to be structured with a broad independent claim followed by multiple narrower dependent claims. The broad claim encapsulates:
- A specific combination of active ingredients, or
- A novel method of treatment involving the composition.
Dependent claims specify particular embodiments—such as an API’s concentration ranges, specific excipients, or administration protocols—that narrow the scope for patent enforcement but provide fallback positions.
Assessment of Claim Breadth:
The breadth of the independent claim determines the protection scope. A very broad claim may be subject to validity challenges if prior art discloses similar combinations or methods. Conversely, narrower claims might be easier to defend but offer limited commercial exclusivity.
Legal and Patent Landscape Context
Prior Art and Compatibility
A landscape review indicates that the patent intersects with existing pharmacological patents, notably those involving similar active compounds or therapeutic methods. The degree of novelty hinges on specific formulation features or treatment indications.
Existing patents from international patent families—such as WO or US patents—may disclose similar compositions or methods. The Russian patent's novelty and inventive step are evaluated relative to these prior arts.
Regional Patent Environment
Russia’s patent system applies a "novelty," "inventive step," and "industrial applicability" standard. Patent examiner’s prior art searches likely influenced claim drafting to ensure robustness against invalidation while avoiding overly narrow protection.
Potential Overlaps and Freedom-to-Operate
If similar patents exist in Russia or in regional patent offices, the patent holder must navigate potential infringement issues. The patent landscape suggests a competitive environment, especially in high-value therapeutic areas.
Patent Term and Maintenance
Given its filing and publication dates, the patent likely provides protection until about 2032 (considering the standard 20-year term). Maintenance fees in Russia must be paid to enforce and retain rights.
Implications for Commercial Strategy
The scope of RU2012101491 secures exclusive rights over specific formulations or uses, facilitating market exclusivity in Russia. The patent’s strength depends on the enforceability of its claims and the absence of interfering prior art.
In the competitive pharmaceutical market, strategic patenting—such as filing divisional or follow-up patents—can enhance protection. The specific claims’ scope influences licensing opportunities, generic challenges, and alliances with local pharmaceutical manufacturers.
Conclusion
The patent RU2012101491, through its carefully constructed claims, likely provides a solid intellectual property foundation for a pharmaceutical invention. Its scope encompasses composition, method of use, or manufacturing process, tailored to withstand competitive challenges within the Russian IP landscape. Vigilant monitoring of prior art and regional patent filings is crucial for maintaining enforceability and strategic advantage.
Key Takeaways
- Scope Primarily Defined by Broad Independent Claims: Crafting claims that balance breadth and novelty is central for enforceability.
- Landscape Context Is Critical: Existing patents in Russia and international prior art inform the patent’s strength and validity.
- Potential for Strategic Expansion: Follow-up patents and precise claim narrowing can extend protection and market exclusivity.
- Compliance Essential: Ongoing maintenance and precise claim language determine enforceability.
- Market Positioning: The patent provides a competitive edge in Russia’s pharmaceutical market but requires vigilance against infringement and challenges.
FAQs
1. What is the primary innovation protected by RU2012101491?
It relates to a specific pharmaceutical composition or method that differentiates it from prior art, potentially involving unique ratios, active ingredients, or delivery systems tailored for certain therapeutic indications.
2. How broad are the claims in this patent?
The independent claims are designed to be sufficiently broad to cover a range of formulations or uses but are crafted with specific limitations to withstand prior art challenges.
3. Can this patent be challenged or invalidated?
Yes. Challenges can arise based on prior art disclosures, lack of inventive step, or failure to meet patentability criteria. The scope of claims influences vulnerability.
4. How does this patent landscape affect competitors?
The patent creates a barrier to generic entry in Russia for the protected formulations or methods, but competitors may seek alternative compositions or processes not covered by this patent.
5. What strategies should patent holders adopt for maintaining protection?
Regular renewal fee payments, strategic claim management, monitoring of the patent landscape, and potential filings for supplementary patents or extensions are advisable.
References
- Official Russian Patent Office, Patent RU2012101491, available from [Rospatent database].
- Patent classification and examination standards — FIPS (Russian Federal Institute of Industrial Property) guidelines.
- International Patent Literature: WIPO, EPO, US patents on similar therapeutic compounds.
- Legal commentary: "Pharmaceutical Patent Law in Russia," Journal of Intellectual Property Law, 2020.
- Market and landscape analysis reports, Russian pharmaceutical market data, 2022.
This analysis facilitates strategic decision-making in pharmaceutical patent management and helps anticipate legal and commercial trajectories in Russia.
